Article Details

Could PD-L1/2 Structural Variants be the Next Pan-Cancer Predictive Immunotherapy Biomarker?

Retrieved on: 2023-01-10 23:09:10

Tags for this article:

Click the tags to see associated articles and topics

Could PD-L1/2 Structural Variants be the Next Pan-Cancer Predictive Immunotherapy Biomarker?. View article details on HISWAI: https://www.precisiononcologynews.com/cancer/could-pd-l12-structural-variants-be-next-pan-cancer-predictive-immunotherapy-biomarker

Excerpt

The identification of PD-L2 structural variants and their biological impact was of particular interest to Roychowdhury's team in this study ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up